D. Molenaar

Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy

R. D. de Haan, M. Vermeulen, R. Haan, 1998, Journal of neurology, neurosurgery, and psychiatry.

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Hester F. Lingsma, E. Steyerberg, R. Hughes, 2021, The Lancet Neurology.

Comparison of electrodiagnostic criteria for demyelination in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)

R. D. de Haan, M. Vermeulen, D. Molenaar, 2002, Journal of Neurology.

Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study.

M. Vermeulen, P. V. van Doorn, D. Molenaar, 1997, Journal of neurology, neurosurgery, and psychiatry.

Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial

P. Willems, W. Vandertop, R. M. Van den Berg-Vos, 2020, The Lancet.

Impact of neurologic signs and symptoms on functional status in peripheral neuropathies

R. D. de Haan, M. Vermeulen, M. de Visser, 1999, Neurology.

Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin

R. Chamuleau, C. Weegink, H. Reesink, 2001, Journal of Gastroenterology.

Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies.

R. D. de Haan, M. Vermeulen, D. Molenaar, 1995, Journal of neurology, neurosurgery, and psychiatry.